New treatment paradigms for optimizing survival in advanced and metastatic breast cancer.
Mayo Clinic Cancer Center, Mayo Clinic, Jacksonville, Florida, USA.
Edith A
EA
Perez
Howard A
HA
Burris
Susan
S
Mooberry
Debu
D
Tripathy
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001691:Biological Therapy; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D008870:Microtubules / Q000187:drug effects; D009362:Neoplasm Metastasis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D050257:Tubulin Modulators / Q000494:pharmacology / Q000627:therapeutic use
D018719:Erb-b2 Receptor Tyrosine Kinases; D050257:Tubulin Modulators; C508053:ERBB2 protein, human